Back to results
US 11,975,067 B2Granted
Coronavirus disease (COVID-19) vaccine
AssigneeThomas Jefferson University
InventorsMatthias Johannes Schnell, Christoph Wirblich, Drishya Kurup
Life of this patent
Estimating the term…
Abstract
The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.
Claims12
A recombinant fusion protein comprising (a) a glycoprotein (G) of a virus or a portion thereof, and (b) a SARS-CoV-2 spike protein (S) or a portion thereof, wherein the SARS-CoV-2 spike protein (S) comprises the amino acid sequence of SEQ ID NO:
- 28, 29, 30, or 31.
Dependencies are inferred from the claim text.